Luis Ospina-Forero

Luis Ospina-Forero

Auto-generated profile, based on publicly available information

Luis Ospina-Forero

Department of Pediatric Ophthalmology and Neuro-Ophthalmology, Sainte-Justine Hospital, University of Montréal, Montréal, Québec, Canada

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2018 in Journal of Chemical Theory and Computation
Verified
Journal Article
Open access
BKBernhard Knapp
Bernhard Knapp
LOLuis Ospina
Luis Ospina
CDCharlotte M. Deane
Charlotte M. Deane
Molecular simulations are a computational technique used to investigate the dynamics of proteins and other molecules. The solution landscape of these simulations is often rugged and minor differences in the initial seed, floating point precision, or underlying hardware can cause identical simulations (replicas) to take different paths in the landscape. In this study we investigated the magnitude of these effects based on 310 000 ns of simulation time. We performed 100 identically parameterised replicas of 3000 ns each for a small 10 amino acid system as well as 100 identically parameterised replicas of 100 ns each for an 827 residue T-cell receptor / MHC system. Comparing randomly chosen subgroups within these replica sets we estimate the reproducibility and reliability that can be achieved by a given number of replicas at a given simulation time. These results demonstrate that conclusions drawn from single simulations are often not reproducible and that conclusions drawn from multiple shorter replicas are more reliable than those from a single longer simulation. The actual number of replicas needed will always depend on the question asked and the level of reliability sought. Based on our data it appears a good rule of thumb is to perform a minimum of five to ten replicas.

3 February 2018 in Journal of Complex Networks
Verified
Journal Article
Closed access
PDF file
AWAnatol E Wegner
Anatol E Wegner
LOLuis Ospina-Forero
Luis Ospina-Forero
RGRobert Gaunt
Robert Gaunt
CDCharlotte M Deane
Charlotte M Deane
GRGesine Reinert
Gesine Reinert
Many complex systems can be represented as networks, and the problem of network comparison is becoming increasingly relevant. There are many techniques for network comparison, from simply comparing network summary statistics to sophisticated but computationally costly alignment-based approaches. Yet it remains challenging to accurately cluster networks that are of a different size and density, but hypothesized to be structurally similar. In this article, we address this problem by introducing a new network comparison methodology that is aimed at identifying common organizational principles in networks. The methodology is simple, intuitive and applicable in a wide variety of settings ranging from the functional classification of proteins to tracking the evolution of a world trade network.

5 January 2019 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
AWAaron W Winter
Aaron W Winter
ASAli Salimi
Ali Salimi
LOLuis H Ospina
Luis H Ospina
JRJonathan C P Roos
Jonathan C P Roos
Gaucher disease (GD) results from a deficiency of glucocerebrosidase activity and the subsequent accumulation of the enzyme’s metabolites, principally glucosylsphingosine and glucosylceramide. There are three principal forms: Type I, which is the most common, is usually considered non-neuronopathic. Type II, III and IIIc manifest earlier and have neurological sequelae due to markedly reduced enzyme activity. Gaucher’s can be associated with ophthalmological sequelae but these have not been systematically reviewed. We therefore performed a comprehensive literature review of all such ophthalmic abnormalities associated with the different types of Gaucher disease. We systematically searched the literature (1950 – present) for functional and structural ocular abnormalities arising in patients with Gaucher disease and found that all subtypes can be associated with ophthalmic abnormalities; these range from recently described intraocular lesions to disease involving the adnexae, peripheral nerves and brain. In summary, Gaucher can affect most parts of the eye. Rarely is it sight-threatening; some but not all manifestations are amenable to treatment, including with enzyme replacement and substrate reduction therapy. Retinal involvement is rare but patients with ocular manifestations should be monitored and treated early to reduce the risk of progression and further complications. As Gaucher disease is also associated with Parkinsons disease and may also confer an increased risk of malignancy (particularly haematological forms and melanoma), any ocular abnormalities should be fully investigated to exclude these potential underlying conditions.

20 August 2018 in Journal of Complex Networks
Verified
Journal Article
Closed access
LOLuis Ospina-Forero
Luis Ospina-Forero
CDCharlotte M Deane
Charlotte M Deane
GRGesine Reinert
Gesine Reinert

10 February 2023 in Physica A: Statistical Mechanics and its Applications
Verified
Journal Article
Open access
LOLuis Ospina-Forero
Luis Ospina-Forero
OGOscar M. Granados
Oscar M. Granados

30 December 2013
Verified
Book
Closed access
JMJuan Camilo Sosa Martínez
Juan Camilo Sosa Martínez
LFLuis Eduardo Ospina Forero
Luis Eduardo Ospina Forero
ECEmilio Pablo Berdugo Camacho
Emilio Pablo Berdugo Camacho